Join the High Cholesterol group to help and get support from people like you.
High Cholesterol News (Page 2)
Related terms: Cholesteremia, Cholesterol, Elevated Levels, Cholesterol, High, Cholesterolemia, Familial Hypercholesterolemia, Hypercholesterolemia, Hypercholesterolemia, Familial, Hyperlipidemia, Lipid Metabolism Disorders
Elevated HDL Cholesterol Linked to Increased Risk for Glaucoma
WEDNESDAY, Feb. 5, 2025 – Elevated high-density lipoprotein cholesterol (HDL-C) is associated with an increased risk for glaucoma, while elevated low-density lipoprotein cholesterol (LDL-C), total...
Variability in Total Cholesterol, LDL Cholesterol Linked to Dementia
MONDAY, Feb. 3, 2025 – Variability in total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) is associated with dementia and cognitive impairment, according to a study published...
Cholesterol Changes in Seniors Linked to Brain Health
THURSDAY, Jan. 30, 2025 – Seniors whose cholesterol levels spike and plummet year-to-year could be at increased risk of dementia and failing brain health, a new study suggests. Those whose...
HDL Cholesterol May Protect Against Brain Atrophy
TUESDAY, Jan. 7, 2025 – High-density lipoprotein (HDL) cholesterol may help conserve healthy brain matter in middle-aged adults, according to a study published online Oct. 18 in the Journal of ...
Women Are Less Likely Than Men to Take Medication After a Stroke, Study Suggests
THURSDAY, Dec. 26, 2024 – Female stroke victims are less likely than men to take drugs that could lower their odds of a second stroke. Women are 80% more likely to report that they don’t take c...
Women Report Less Poststroke Medication Adherence Than Men
TUESDAY, Dec. 10, 2024 – Poststroke medication nonadherence is more prevalent among U.S. women than men, according to a study published online Dec. 4 in the Journal of the American Heart...
Lower Levels of Total Cholesterol Seen in More Recent Birth Cohorts
FRIDAY, Dec. 6, 2024 – More recent birth cohorts have lower levels of total cholesterol and fasting triglyceride levels, and higher levels of fasting glucose, according to a study published online...
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk
MONDAY, Nov. 25, 2024 – Muvalaplin reduces lipoprotein(a) levels, according to a study published online Nov. 20 in the Journal of the American Medical Association to coincide with the American Heart...
Prevalence of High Total Cholesterol 11.3 Percent in U.S. Adults
WEDNESDAY, Nov. 20, 2024 – The prevalence of high total cholesterol was 11.3 percent among U.S. adults in August 2021 to August 2023, according to a November data brief published by the National...
About 1 in 10 U.S. Adults Have High Cholesterol
WEDNESDAY, Nov. 20, 2024 – Nearly 1 in every 10 American adults is living with high levels of cholesterol in their arteries, according to the latest report from the U.S. Centers for Disease Control...
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
WEDNESDAY, Oct. 30, 2024 – There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29...
Study Reveals No Link Between HDL Cholesterol and Movement Disorders
FRIDAY, Sept. 20, 2024 – There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing movement disorders while taking an antipsychotic, a...
U.S. FDA Approves Broad New Labels for Nexletol and Nexlizet to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
ANN ARBOR, Mich., March 22, 2024 (GLOBE NEWSWIRE) – Esperion (NASDAQ: ESPR) today announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for...
Praluent (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
TARRYTOWN, N.Y., March 11, 2024 (GLOBE NEWSWIRE) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the U.S. Food & Drug Administration (FDA) has extended the approval of Praluent® ...
U.S. FDA Updates LDL-C Lowering Indication for Esperion’s Nexletol (bempedoic acid) Tablet and Nexlizet (bempedoic acid and ezetimibe) Tablet
Updated Label Adds Primary Hyperlipidemia, Removes Maximally Tolerated Statin Requirement, Removes Limitation of Use Cardiovascular (CV) Risk Reduction Labels Remain on Track: in U.S. with PDUFA...
Further information
Related condition support groups
High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Cardiovascular Conditions and Disorders
Related drug support groups
atorvastatin, simvastatin, Repatha, pravastatin, Crestor, ezetimibe, Zetia, cholestyramine, rosuvastatin, niacin, garcinia cambogia, garlic, Leqvio